Ads
-
Related paper
- DYSLIPIDEMIA: OVERVIEW OF THE ESC/EAS 2019 RECOMMENDATIONS FOR DIAGNOSTICS AND TREATMENT. PART 1 – RISK ASSESSMENT
- DYSLIPIDEMIA: OVERVIEW OF THE ESC/EAS 2019 RECOMMENDATIONS FOR DIAGNOSTICS AND TREATMENT. PART 2 – TARGET THERAPY
- Assessment of stakeholder satisfaction. Part 1. Overview of assessment methods
- CURRENT APPROACHES TO ACUTE RENAL FAILURE ASSESSMENT (CLASSIFICATION, DIAGNOSTICS) PART I
- ASSESSMENT OF THE LEVEL OF ENSURING THE ECONOMIC SECURITY OF THE ENTERPRISE AS PART OF THE IMPLEMENTATION OF COMPETITIVE RISK STRATEGIES
- Dyslipidemia in psoriasis: as a risk for cardiovascular disease
- Dyslipidemia Causes, Symptoms and Treatment
- Primary dyslipidemia and cardiometabolic risk: potential of pitavastatin
- An Overview of Breast Cancer Screening Recommendations
- PREVALENCE OF DYSLIPIDEMIA AND OTHER CARDIOVASCULAR RISK FACTORS (HYPERTENSION AND DIABETES) IN MEDICAL PROFESSIONALS